Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
496.2 GBX | -0.86% | -1.35% | -7.29% |
May. 25 | Sunak's summer election brings hope to Britain's bruised financial sector | RE |
May. 24 | Sunak's summer election brings hope to Britain's bruised financial sector | RE |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The stock, which is currently worth 2024 to 0.55 times its sales, is clearly overvalued in comparison with peers.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- This company will be of major interest to investors in search of a high dividend stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- With an expected P/E ratio at 195.82 and 34.46 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company appears highly valued given the size of its balance sheet.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-7.29% | 6.31B | A- | ||
+12.07% | 78.88B | B- | ||
+9.44% | 51.46B | B+ | ||
+8.93% | 51.07B | B | ||
+20.90% | 46.59B | B+ | ||
+16.04% | 43.21B | B+ | ||
+23.53% | 39.69B | B | ||
-0.60% | 29.1B | B | ||
-6.79% | 27.94B | B- | ||
-15.80% | 26.05B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- PHNX Stock
- Ratings Phoenix Group Holdings plc